1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Ignyta Acquires Actagene Oncology

M&A Deal Summary

Ignyta Acquires Actagene Oncology

On May 20, 2013, Ignyta acquired life science company Actagene Oncology

Acquisition Highlights
  • This is Ignyta’s 1st transaction in the Life Science sector.
  • This is Ignyta’s 1st transaction in the United States.
  • This is Ignyta’s 1st transaction in California.

M&A Deal Summary
Date 2013-05-20
Target Actagene Oncology
Sector Life Science
Buyer(s) Ignyta
Deal Type Add-on Acquisition

Target

Actagene Oncology

San Diego, California, United States
Actagene Oncology, Inc. develops personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Ignyta

San Diego, California, United States
Category Company
Founded 2011
Sector Life Science
Employees115
DESCRIPTION

Ignyta, Inc. is a trailblazing biotechnology company catalyzing personalized medicine with integrated Rx/Dx solutions for cancer and immunology. Ignyta was founded in 2011 and is based in San Diego, California.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2013 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal